H.R. 965: CREATES Act of 2019

CBO Score

$-3,415,000,000

Version

Documentation

Date of Report

Wed May 8th, 2019

CBO Report Details

Legislation Details

116th Congress

To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.

Sponsor: Rep. David Cicilline — D — RI

To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.

View the full vote history of this bill on GovTrack.us.

As a registered user, you receive personalized updates to your inbox or dashboard when elected officials vote to spend more of your money. Choose to receive updates daily, weekly, monthly, or as they happen.

JOIN US!

Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.

Lost your Password?

Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.

×
+ + HIGH LOW +
+ + HIGH LOW +